FOXP3 and neoplasm: Through the 2000s, work on apoptotic signaling and regulatory pathways revealed that tumor cells could actively subvert immunity through Fas–FasL interactions, recruitment of FOXP3+ regulatory T-cells, and downregulation of vascular adhesion molecules, establishing the concept of tumor-driven immune evasion [24,33,35,36].